Evaluation of DNA repair inhibition by antitumor or antibiotic drugs using a chemiluminescence microplate assay

Carcinogenesis

Volumn 18, Issue 12, 1997, Pages 2441-2445

  Barret, Jean Marc ^a   Salles, Bernard ^b   Provot, Christian ^c   Hill, Bridget T ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c Soc Francaise Rech d'I   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; APHIDICOLIN; DACTINOMYCIN; DISTAMYCIN A; DOXORUBICIN; MITHRAMYCIN;

ARTICLE; CHEMOLUMINESCENCE; EXCISION REPAIR; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CHEMILUMINESCENT MEASUREMENTS; DNA REPAIR; DNA, BACTERIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HUMANS; METHODS; PLASMIDS; ULTRAVIOLET RAYS;

EID: 0031409892     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.12.2441     Document Type: Article

References (24)

1. Chaney, S.G. and Sancar, A. (1996) DNA repair: enzymatic mechanisms and relevance to drug response. J. Natl. Cancer Inst., 88, 1346-1360.
2. Sancar, A. (1995) DNA repair in humans. Annu. Rev. Genet., 29, 69-105.
3. Sancar, A. (1996) DNA excision repair. Annu. Rev. Biochem., 65, 43-81.
4. Calsou, P. and Salles, B. (1993) Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin. Cancer Chemother. Pharmacol., 32, 85-89.
5. Salles, B., Frit, P., Provot, C., Jaeg, J.-P. and Calsou, P. (1995) In vitro eukaryotic DNA excision repair assays: An overview. Biochimie, 77, 796-802.
6. Wood, R.D., Robins, P. and Lindhal, T. (1988) Complementation of the xeroderma pigmentosum DNA repair defect in cell-free extracts. Cell, 53, 97-106.
7. Salles, B., Provot, C., Calsou, P., Henebelle, I., Gosset, I. and Fournié, G.J. (1995) A chemiluminescent microplate assay to detect DNA damage induced by genotoxic treatments. Anal. Biochem., 232, 37-42.
8. Provot, C., Salles, B., Calsou, P. and Fournié, G. (1995) French Patent No. 9503230.
9. Gedik, C.M. and Collins, A.R. (1990) Comparison of effects of fostriecin, novobiocin, and camptothecin, inhibitors of DNA topoisomerases, on DNA replication and repair in human cells. Nucleic Acids Res., 18, 1007-1012.
10. Popanda, O. and Thielmann, H.W. (1992) The function of DNA topoisomerases in UV-induced DNA excision repair: studies with specific inhibitors in permeabilized human fibroblasts. Carcinogenesis, 13, 2321-2328.
11. Stevnsner, T. and Bohr, V.A. (1993) Studies on the role of topoisomerases in general, gene-and strand-specific DNA repair. Carcinogenesis, 14, 1841-1850.
12. Thielmann, H.W., Popanda, O., Gersbach, H. and Gilberg, F. (1993) Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts. Carcinogenesis, 14, 2341-2351.
13. Hill, B.T., Douglas, I.D.C. and Grover, P.L. (1973) Increased antitumour activity of chlorambucil following pretreatment with inducers of drug-metabolizing enzymes. Biochem. Pharmacol., 22, 1083-1089.
14. Cummings, J., Spanswick, V.J. and Smyth, J.F. (1995) Re-evaluation of the molecular pharmacology of mitomycin C. Eur. J. Cancer, 31A, 1928-1933.
15. Sinhababu, A.K. and Thakker, D.R. (1996) Prodrugs of anticancer agents. Adv. Drug Deliv. Rev., 19, 241-273.
16. Matherly, L.H., Seither, R.L. and Goldman, I.D. (1987) Metabolism of the diaminoantifolates: biosynthesis and pharmacology of the 7-hydroxyl and polyglutamyl metabolites of metotrexate and related antifolates. Pharmacol. Ther., 35, 27-32.
17. Barret, J.-M., Calsou, P., Kragh-Larsen, A. and Salles, B. (1994) A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity. Mol. Pharmacol., 46, 431-436.
18. Eder Jr., J.P., Chan, V.T.-W., Ng, C-W., Rizvi, N.A., Zacharoulis, S., Teicher, B.A. and Schnipper, L.E. (1995) DNA topoisomerase II α expression is associated with alkylating agent resistance. Cancer Res., 55, 6109-6116.
19. Worth Jr., L., Frank, B.L., Christner, D.F., Absalon, M.J., Stubbe, J. and Kozarich, J.W. (1993) Isotope effects on the cleavage of DNA by bleomycin: Mechanism and modulation. Biochemistry, 32, 26-2609.
20. Gogas, H. and Mansi, J.L. (1995) The anthrapyrazoles. Cancer Treat. Rev., 21, 541-552.
21. Bramson, J. and Panasci, L. (1995) Potentiation of chlorambucil toxicity in B-CLL lymphocytes using the DNA synthesis inhibitors aphidicolin and 1-β-D-arabinofuranosylcytosine. Biochem. Pharmacol., 50, 131-135.
22. Sargent, J.M., Elgie, A.W., Williamson, C.J. and Taylor, C.G. (1996) Aphidicolin marketly increases the platinum sensitivity of cells from primary ovarian tumours. Br. J. Cancer, 74, 1730-1733.
23. Moynihan, K., Elion, G.B., Ali-Osman, F., Marcelli, S., Keir, S., Bigner, D.D. and Friedman, H.S. (1996) Enhancement of melphalan activity by inhibition of DNA polymerase -α and DNA-polymerase β. Cancer Chemother. Pharmacol., 38, 349-354.
24. Li, L., Liu, X.-M., Glassman, A.B., Keating, M.J., Stros, M., Plunkett, W. and Yang, L.-Y. (1997) Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. Cancer Res., 57, 1487-1494.